Assenagon Asset Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$35.6M Buy
1,247,992
+20,189
+2% +$435K 0.04% 298
2026
Q1
$14.1M Buy
1,227,803
+587,043
+92% +$8.27M 0.02% 395
2025
Q4
$9.21M Buy
+640,760
New +$11.1M 0.01% 525
2025
Q3
Sell
-599,488
Closed -$12.9M 1247
2025
Q2
$12.9M Buy
599,488
+584,421
+3,879% +$8.69M 0.02% 426
2025
Q1
$198K Sell
15,067
-417,647
-97% -$6.2M ﹤0.01% 1114
2024
Q4
$5.82M Sell
432,714
-541,077
-56% -$8.71M 0.01% 650
2024
Q3
$20.7M Sell
973,791
-1,072,255
-52% -$19.3M 0.04% 333
2024
Q2
$32.4M Buy
2,046,046
+507,009
+33% +$9.32M 0.07% 204
2024
Q1
$22.9M Buy
1,539,037
+806,752
+110% +$11M 0.05% 252
2023
Q4
$6.7M Sell
732,285
-327,244
-31% -$2.26M 0.02% 554
2023
Q3
$5.9M Buy
1,059,529
+347,424
+49% +$2.43M 0.02% 539
2023
Q2
$5.74M Buy
712,105
+500,715
+237% +$3.69M 0.02% 471
2023
Q1
$1.38M Buy
211,390
+11,755
+6% +$48K ﹤0.01% 955
2022
Q4
$491K Buy
+199,635
New +$624K ﹤0.01% 1174

Other funds holding OSCR

Assenagon Asset Management's OSCR Position: Q2 2026 in Review

Assenagon Asset Management increased its Oscar Health (OSCR) stake by 1.6% in Q2 2026, buying an estimated $435K and bringing the position to 1,247,992 shares worth $35.6M. The position accounts for 0.04% of the portfolio, ranked #298.

Assenagon Asset Management first reported a position in OSCR in Q4 2022 and has held it in 14 quarters since. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Assenagon Asset Management held 1,247,992 shares of Oscar Health worth $35.6M as of Q2 2026.
  • Assenagon Asset Management bought 20,189 Oscar Health shares in Q2 2026, an estimated $435K.
  • Oscar Health made up 0.04% of Assenagon Asset Management's portfolio in Q2 2026, its #298 holding.
  • Assenagon Asset Management first reported a position in Oscar Health in Q4 2022 and has held it in 14 quarters since.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.